Insights Newsletter September 2025: Emerging Trends for Clinical Leadership

September 12, 2025

This month’s Insights Newsletter covers the latest practice-changing pharmacy updates, emerging trends, and popular natural medicine topics and resources.

Insights Newsletter | September 2025

Read Newsletter

Answer Questions About 2025-2026 Flu Vaccines

Subscribers will need to be ready to give guidance about this year’s flu vaccines, especially as confusion and misinformation abounds. Our Letter articles discuss which patients should get vaccinated along with which vaccine to recommend. We also give guidance on how to address concerns about thimerosal exposure and explain the difference among various medical organizations’ recommendations. Finally, we point out what’s new with flu vaccines for the coming season. Readers can use our Flu Vaccines for 2025-26 chart to compare products and review our resource, Communicating About Flu Vaccination, for answers to FAQs about immunizing patients who are pregnant, have an egg allergy, and more. Read More

Community Pharmacies: Help Patients Send Their Vaping Habits Up in Smoke

Educating patients about the dangers of e-cigarettes is crucial, especially with rising adult vaping rates. Our Letter articles discuss the unique barriers to vaping cessation, such as tracking consumption and the lack of FDA-approved medications. However, we give guidance on an approach for patients that includes considering varenicline or combination nicotine replacement therapy. Readers can compare options with our Smoking Cessation Drug Therapy chart and get answers to other common questions in our E-Cigarettes and Vaping FAQ. Read More

Hospitals: Demystify Aztreonam/Avibactam for Abdominal Infections

Your team will start to hear about aztreonam/avibactam (Emblaveo), a new IV antibiotic for complicated intra-abdominal infections (cIAI) that’s active against extended-spectrum beta-lactamases and some carbapenemases. Our Letter articles discuss its limited evidence base, high cost, and the need for formulary restrictions. Additionally, we provide guidance on its role in therapy, dosing, and administration. Readers can check out our aztreonam/avibactam quick skim graphic for a snapshot of dosing, administration, and more. Read More

Natural Medicines: Natural Food Colors 101

People will have questions about natural food colors, as more popular brands of candy, cereal, and other foods remove artificial colors from their products. Our NatMed article reviews some natural colors recently approved by FDA, such as butterfly pea flower, calcium phosphate, and gardenia blue. We discuss FDA’s process for evaluating color additives, and we advise consumers to check labels to determine which natural or synthetic colors are used Read More

Pharmacy & Prescriber Podcasts

Medication Talk

Listen to this month’s podcast episode, Meds After Acute Coronary Syndrome, as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You’ll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.

All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.

Rumor vs Truth

Listen to or watch the latest episode, Managing Acne, as hosts Don and Steve tackle one of the most common (and commonly misunderstood) skin conditions: acne. Joined by dermatology expert Sara Klockars, PharmD, BCPS, the team breaks down the myths, meds, and marketing claims that surround acne treatment.

Clinical Capsules

Listen to our latest episode, New Twists to Old Meds: Fresh Formulations of Losartan, Minocycline, and More, as TRC Healthcare editor, Vickie Danaher, PharmD, discusses recently approved drug formulations that bring fresh options—and new challenges—to the pharmacy counter.